Test Code MRSAP Methicillin Resistant Staphylococcus aureus, PCR, Nasal
Specimen Required
Specimen Type: Nasal cavity swab
Supplies: BD E-Swab (T853)
Container/Tube:
Preferred: BD Liquid Amies Elution Swab (E-Swab)
Acceptable: Copan Liquid Amies Elution Swab (ESwab); Cepheid nasal sample collection device (dual swab in liquid Stuart media); or Copan swab and transport systems (LQ Stuart or LQ Amies) (scored swabs only)
Specimen Volume: Entire collection
Collection Instructions:
1. Ask the patient to blow their nose prior to collection.
2. Use one swab for both right and left nares.
3. Insert the white Dacron swab tip (do not insert any further in) into the anterior nares.
4. Rotate the swab for 3 seconds against the nasal mucosa. Apply slight pressure on the outside of the nose with your finger to ensure good contact.
5. Repeat the process on the other nostril.
6. Insert the swab back into the carrier. The swabs should go all the way into the transport container. Tightly cap the container.
7. Label the transport container with patient label and send refrigerate.
Secondary ID
609735Useful For
Rapid screening test for Staphylococcus aureus nasal carriage that, if positive, indicates whether the S aureus is methicillin susceptible or resistant
This test should not be used to guide or monitor treatment for methicillin-resistant S aureus or S aureus infections.
Highlights
This test provides rapid presurgical screening of patients for colonization of Staphylococcus aureus and methicillin-resistant S aureus in the nasal cavity
Method Name
Real-Time Polymerase Chain Reaction (PCR)
Reporting Name
Staph aureus/MRSA, Nasal, PCRSpecimen Type
SwabSpecimen Minimum Volume
See Specimen Required.
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Swab | Refrigerated (preferred) | 5 days | |
Ambient | 24 hours |
Reject Due To
Incorrect swab collection/non-scored swabs | Reject |
Clinical Information
Staphylococcus aureus causes a variety of human infections and is a major cause of hospital acquired infection of surgical wounds and infections associated with indwelling medical devices. Mayo Clinic has established a program to reduce the number of S aureus surgical infections, which involves surgical patients being tested for S aureus and treated, if positive, prior to surgery. This assay not only detects S aureus, but, if positive, indicates whether S aureus is methicillin susceptible or resistant.
Reference Values
Negative for Staphylococcus aureus
Negative for methicillin-resistant S aureus
Interpretation
A positive result indicates presence of DNA from Staphylococcus aureus. The assay also detects the gene for methicillin resistance (mecA).
A negative result indicates the absence of detectable S aureus DNA in the specimen.
Method Description
The GeneXpert Dx System automates and integrates sample purification, nucleic acid amplification, and detection of the target sequence in simple or complex samples using real-time polymerase chain reaction (PCR). The system uses single-use disposable cartridges that hold the PCR reagents and host the PCR process. Because the cartridges are self-contained, cross-contamination between samples is minimized.
The Cepheid Xpert SA Nasal Complete Assay performed in the GeneXpert System is a qualitative in vitro diagnostic test designed for rapid detection of Staphylococcus aureus and methicillin-resistant S aureus (MRSA) from nasal swabs in patients at risk for nasal colonization. The test utilizes automated PCR for qualitative detection of proprietary sequences for the staphylococcal protein A (spa) gene, the gene for methicillin resistance (mecA), and the staphylococcal MRSA/SA S aureus DNA cassette chromosome mec (SCCmec) inserted into the S aureus chromosomal attB site. The assay includes a sample processing control to ensure the sample was processed correctly and to monitor for the presence of inhibitors in the PCR reaction. A probe check control verifies reagent rehydration, PCR tube filling in the cartridge, probe integrity, and dye stability.(Package insert: Xpert SA Nasal Complete 300-8799. Cepheid; Rev H, 09/2019)
Day(s) Performed
Monday through Sunday
Performing Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
87641
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
MRSAP | Staph aureus/MRSA, Nasal, PCR | 72887-3 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
MSSAC | Staphylococcus aureus, PCR | 79447-9 |
MRSAC | MRSA, PCR | 72887-3 |